Phesgo and Tecentriq Performance and Approvals slide image

Phesgo and Tecentriq Performance and Approvals

Q1 2023: Pharmaceuticals Division sales All regions delivering strong growth 2023 2022 Change in % CHFM CHFM CHF CER Pharmaceuticals Division 11,699 11,159 5 9 United States 5,853 5,489 7 6 Europe 2,071 2,072 0 5 Japan 1,390 1,337 4 18 International 2,385 2,261 5 13 CER=Constant Exchange Rates Roche 17
View entire presentation